Awardee: Robin Ketteler
Institution: UCL MRC Laboratory for Molecular Cell Biology
Award Amount: $51,020
Funding Period: February 1, 2019 - January 31, 2020
The use of a patient-centric neuronal cell model of Beta-Propeller Protein-Associated Neurodegeneration (BPAN) as a platform to develop novel therapies
Previous
Previous
Small molecule modulators of telomerase as novel treatments for dyskeratosis congenita
Next
Next